688710 益诺思
已收盘 07-27 15:00:01
资讯
新帖
简况
7月22日益诺思涨7.41%,平安医疗健康混合A基金重仓该股
证券之星 · 07-22
7月22日益诺思涨7.41%,平安医疗健康混合A基金重仓该股
7月20日益诺思涨5.96%,平安医疗健康混合A基金重仓该股
证券之星 · 07-20
7月20日益诺思涨5.96%,平安医疗健康混合A基金重仓该股
每周股票复盘:益诺思(688710)因股价涨幅偏离值累计达30%登龙虎榜
证券之星 · 07-19
每周股票复盘:益诺思(688710)因股价涨幅偏离值累计达30%登龙虎榜
益诺思(688710)披露关于2025年年度报告信息披露监管问询函的回复公告,7月17日股价下跌14.59%
证券之星 · 07-17
益诺思(688710)披露关于2025年年度报告信息披露监管问询函的回复公告,7月17日股价下跌14.59%
7月17日益诺思跌14.59%,平安医疗健康混合A基金重仓该股
证券之星 · 07-17
7月17日益诺思跌14.59%,平安医疗健康混合A基金重仓该股
7月16日益诺思跌5.47%,平安医疗健康混合A基金重仓该股
证券之星 · 07-16
7月16日益诺思跌5.47%,平安医疗健康混合A基金重仓该股
益诺思(688710)披露股票交易异常波动公告,7月13日股价上涨7.9%
证券之星 · 07-13
益诺思(688710)披露股票交易异常波动公告,7月13日股价上涨7.9%
7月13日益诺思(688710)龙虎榜数据:机构净卖出7055.32万元,北向资金净卖出3183.74万元
证券之星 · 07-13
7月13日益诺思(688710)龙虎榜数据:机构净卖出7055.32万元,北向资金净卖出3183.74万元
7月13日益诺思涨7.90%,平安医疗健康混合A基金重仓该股
证券之星 · 07-13
7月13日益诺思涨7.90%,平安医疗健康混合A基金重仓该股
每周股票复盘:益诺思(688710)因股价涨幅达15%登龙虎榜
证券之星 · 07-12
每周股票复盘:益诺思(688710)因股价涨幅达15%登龙虎榜
7月10日益诺思(688710)龙虎榜数据:机构净买入53.07万元,北向资金净卖出226.45万元
证券之星 · 07-10
7月10日益诺思(688710)龙虎榜数据:机构净买入53.07万元,北向资金净卖出226.45万元
7月10日益诺思涨20.00%,平安医疗健康混合A基金重仓该股
证券之星 · 07-10
7月10日益诺思涨20.00%,平安医疗健康混合A基金重仓该股
异动快报:益诺思(688710)7月10日14点9分触及涨停板
证券之星 · 07-10
异动快报:益诺思(688710)7月10日14点9分触及涨停板
每周股票复盘:益诺思(688710)增补两名非独立董事
证券之星 · 07-05
每周股票复盘:益诺思(688710)增补两名非独立董事
益诺思(688710)披露2026年第一次临时股东会决议公告,6月30日股价下跌1.29%
证券之星 · 06-30
益诺思(688710)披露2026年第一次临时股东会决议公告,6月30日股价下跌1.29%
6月29日益诺思涨5.24%,平安医疗健康混合A基金重仓该股
证券之星 · 06-29
6月29日益诺思涨5.24%,平安医疗健康混合A基金重仓该股
每周股票复盘:益诺思(688710)将召开临时股东会审议董事薪酬及增补两名非独立董事
证券之星 · 06-28
每周股票复盘:益诺思(688710)将召开临时股东会审议董事薪酬及增补两名非独立董事
益诺思(688710)披露2026年第一次临时股东会会议资料,6月24日股价上涨3.95%
证券之星 · 06-24
益诺思(688710)披露2026年第一次临时股东会会议资料,6月24日股价上涨3.95%
益诺思涨5.22%,开源证券二个月前给出“买入”评级
证券之星 · 06-22
益诺思涨5.22%,开源证券二个月前给出“买入”评级
益诺思涨6.49%,开源证券二个月前给出“买入”评级
证券之星 · 06-18
益诺思涨6.49%,开源证券二个月前给出“买入”评级
加载更多
公司概况
公司名称:
上海益诺思生物技术股份有限公司
所属行业:
研究和试验发展
上市日期:
2024-09-03
主营业务:
上海益诺思生物技术股份有限公司的主营业务是提供生物医药非临床研究服务为主的综合研发服务(CRO)。公司的主要产品是非临床CRO、临床CRO。公司荣膺医药魔方“中国创新药十年荣耀榜·行业引领CRO公司”、药融圈“中国新药临床前CRO排名TOP20”、每日经济新闻“2025上市公司最具社会责任奖”、《证券市场周刊》“金曙光新质生产力奖”等系列荣誉,并凭借在体内CAR-T领域的突出贡献,成为同写意“体内CAR-T新基建联盟成员机构”;同时获评石药集团“2025最佳合作单位”。
发行价格:
19.06
{"stockData":{"symbol":"688710","market":"SH","secType":"STK","nameCN":"益诺思","latestPrice":78.83,"timestamp":1785135601000,"preClose":76.9,"halted":0,"volume":3456185,"delay":0,"changeRate":0.0251,"floatShares":90694000,"shares":141000000,"eps":-0.1691,"marketStatus":"已收盘","change":1.93,"latestTime":"07-27 15:00:01","open":74.48,"high":81.22,"low":74.48,"amount":269000000,"amplitude":0.0876,"askPrice":78.83,"askSize":8,"bidPrice":78.82,"bidSize":6,"shortable":0,"etf":0,"ttmEps":-0.1691,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785202200000},"marketStatusCode":5,"adr":0,"adjPreClose":76.9,"symbolType":"stock_kcb","openAndCloseTimeList":[[1785115800000,1785123000000],[1785128400000,1785135600000]],"highLimit":84.59,"lowLimit":69.21,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":140979615,"isCdr":false,"pbRate":4.75,"roa":"--","roe":"0.52%","epsLYR":-0.22,"committee":0.580645,"marketValue":11113000000,"turnoverRate":0.0381,"status":0,"afterMarket":{"amount":15766,"volume":200,"close":78.83,"buyVolume":800,"sellVolume":0,"time":1785137637746,"indexStatus":"已收盘 07-27 15:30:00","preClose":76.9},"floatMarketCap":7149000000},"requestUrl":"/m/hq/s/688710","defaultTab":"news","newsList":[{"id":"2653531287","title":"7月22日益诺思涨7.41%,平安医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653531287","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653531287?lang=zh_cn&edition=full","pubTime":"2026-07-22 16:48","pubTimestamp":1784710083,"startTime":"0","endTime":"0","summary":"证券之星消息,7月22日益诺思涨7.41%,收盘报80.6元,换手率5.5%,成交量4.99万手,成交额4.03亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共43家,其中持有数量最多的公募基金为平安基金的平安医疗健康混合A。平安医疗健康混合A目前规模为17.61亿元,最新净值2.3368,较上一交易日上涨1.58%,近一年下跌18.91%。平安医疗健康混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200034587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","159760","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652610296","title":"7月20日益诺思涨5.96%,平安医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652610296","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652610296?lang=zh_cn&edition=full","pubTime":"2026-07-20 16:34","pubTimestamp":1784536481,"startTime":"0","endTime":"0","summary":"证券之星消息,7月20日益诺思涨5.96%,收盘报69.3元,换手率6.27%,成交量5.69万手,成交额3.92亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共32家,其中持有数量最多的公募基金为平安基金的平安医疗健康混合A。平安医疗健康混合A目前规模为17.03亿元,最新净值2.1966,较上一交易日下跌9.49%,近一年下跌23.63%。平安医疗健康混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000024722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159760","688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652923795","title":"每周股票复盘:益诺思(688710)因股价涨幅偏离值累计达30%登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2652923795","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652923795?lang=zh_cn&edition=full","pubTime":"2026-07-19 01:22","pubTimestamp":1784395331,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘,益诺思报收于65.4元,较上周的77.87元下跌16.01%。本周,益诺思7月15日盘中最高价报91.19元,股价触及近一年最高点。来自公司公告汇总:益诺思2025年归母净利润亏损3,051.59万元,营业收入同比下降28.94%。公司公告汇总关于股票交易异常波动的公告上海益诺思生物技术股份有限公司股票于2026年7月10日、2026年7月13日连续两个交易日内收盘价格涨幅偏离值累计超过30%,构成股票交易异常波动。境外业务收入同比增长102.91%,毛利率达41.25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652286277","title":"益诺思(688710)披露关于2025年年度报告信息披露监管问询函的回复公告,7月17日股价下跌14.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652286277","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652286277?lang=zh_cn&edition=full","pubTime":"2026-07-17 22:05","pubTimestamp":1784297126,"startTime":"0","endTime":"0","summary":"近日,上海益诺思生物技术股份有限公司发布《关于2025年年度报告信息披露监管问询函的回复公告》。公告显示,公司就2025年年度报告收到上证科创板监管问询函,针对营业收入、毛利率、客户与供应商、往来款项、存货及生物性资产等问题进行了详细回复。公司2025年实现营业收入8.11亿元,同比下降28.94%,归母净利润亏损3,051.59万元。境外业务收入同比增长102.91%,毛利率达41.25%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700044490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652883406","title":"7月17日益诺思跌14.59%,平安医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652883406","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652883406?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:35","pubTimestamp":1784277319,"startTime":"0","endTime":"0","summary":"证券之星消息,7月17日益诺思跌14.59%,收盘报65.4元,换手率8.68%,成交量7.88万手,成交额5.42亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共32家,其中持有数量最多的公募基金为平安基金的平安医疗健康混合A。平安医疗健康混合A目前规模为17.03亿元,最新净值2.4269,较上一交易日下跌1.21%,近一年下跌12.12%。平安医疗健康混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700030166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159760","BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651412025","title":"7月16日益诺思跌5.47%,平安医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651412025","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651412025?lang=zh_cn&edition=full","pubTime":"2026-07-16 16:24","pubTimestamp":1784190250,"startTime":"0","endTime":"0","summary":"证券之星消息,7月16日益诺思跌5.47%,收盘报76.57元,换手率7.91%,成交量7.18万手,成交额5.59亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共32家,其中持有数量最多的公募基金为平安基金的平安医疗健康混合A。平安医疗健康混合A目前规模为17.03亿元,最新净值2.4567,较上一交易日上涨6.0%,近一年下跌10.75%。平安医疗健康混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600026144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159760","BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651698117","title":"益诺思(688710)披露股票交易异常波动公告,7月13日股价上涨7.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651698117","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651698117?lang=zh_cn&edition=full","pubTime":"2026-07-13 22:07","pubTimestamp":1783951639,"startTime":"0","endTime":"0","summary":"截至2026年7月13日收盘,益诺思报收于84.02元,较前一交易日上涨7.9%,最新总市值为118.45亿元。该股当日开盘78.87元,最高84.58元,最低76.51元,成交额达7.07亿元,换手率为9.66%。近日,益诺思发布《关于股票交易异常波动的公告》。公告显示,公司股票于2026年7月10日、2026年7月13日连续两个交易日内收盘价格涨幅偏离值累计超过30%,构成股票交易异常波动。公司目前生产经营正常,未发生重大变化。董事会确认无应披露未披露事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300039889.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651118318","title":"7月13日益诺思(688710)龙虎榜数据:机构净卖出7055.32万元,北向资金净卖出3183.74万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651118318","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651118318?lang=zh_cn&edition=full","pubTime":"2026-07-13 17:58","pubTimestamp":1783936701,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年7月13日公布的交易公开信息显示,益诺思因有价格涨跌幅限制的连续3个交易日内收盘价格涨幅偏离值累计达到30%的证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2026年7月13日收盘,益诺思报收于84.02元,上涨7.9%,换手率9.66%,成交量8.76万手,成交额7.07亿元。从龙虎榜公布的当日买卖数据来看,机构合计净卖出7055.32万元,北向资金合计净卖出3183.74万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300027247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651947591","title":"7月13日益诺思涨7.90%,平安医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651947591","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651947591?lang=zh_cn&edition=full","pubTime":"2026-07-13 16:37","pubTimestamp":1783931823,"startTime":"0","endTime":"0","summary":"证券之星消息,7月13日益诺思涨7.90%创60日新高,收盘报84.02元,换手率9.66%,成交量8.76万手,成交额7.07亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共32家,其中持有数量最多的公募基金为平安基金的平安医疗健康混合A。平安医疗健康混合A目前规模为17.03亿元,最新净值2.3132,较上一交易日上涨4.39%,近一年下跌9.37%。平安医疗健康混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300023462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","159760","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650151207","title":"每周股票复盘:益诺思(688710)因股价涨幅达15%登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2650151207","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650151207?lang=zh_cn&edition=full","pubTime":"2026-07-12 01:37","pubTimestamp":1783791427,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘,益诺思报收于77.87元,较上周的62.67元上涨24.25%。本周,益诺思7月10日盘中最高价报77.87元,股价触及近一年最高点。本周关注点来自交易信息汇总:益诺思因日收盘价格涨幅达到15%登上龙虎榜。此次是近5个交易日内第1次上榜。公司公告汇总上海益诺思生物技术股份有限公司于2026年7月10日发布公告,经第三届董事会第二十六次会议审议通过,对公司部分治理制度进行制定及修订。违反规定买卖股票所得收益归公司所有。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200000342.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650718603","title":"7月10日益诺思(688710)龙虎榜数据:机构净买入53.07万元,北向资金净卖出226.45万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650718603","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650718603?lang=zh_cn&edition=full","pubTime":"2026-07-10 17:29","pubTimestamp":1783675765,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年7月10日公布的交易公开信息显示,益诺思因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年7月10日收盘,益诺思报收于77.87元,上涨20.0%,涨停,换手率7.56%,成交量6.86万手,成交额5.03亿元。从龙虎榜公布的当日买卖数据来看,机构合计净买入53.07万元,北向资金合计净卖出226.45万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000031631.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650946183","title":"7月10日益诺思涨20.00%,平安医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650946183","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650946183?lang=zh_cn&edition=full","pubTime":"2026-07-10 16:27","pubTimestamp":1783672020,"startTime":"0","endTime":"0","summary":"证券之星消息,7月10日益诺思涨20.00%创60日新高,收盘报77.87元,换手率7.56%,成交量6.86万手,成交额5.03亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共32家,其中持有数量最多的公募基金为平安基金的平安医疗健康混合A。平安医疗健康混合A目前规模为17.03亿元,最新净值2.216,较上一交易日上涨0.86%,近一年下跌14.31%。平安医疗健康混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000028978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216","159760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650902566","title":"异动快报:益诺思(688710)7月10日14点9分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2650902566","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650902566?lang=zh_cn&edition=full","pubTime":"2026-07-10 14:10","pubTimestamp":1783663840,"startTime":"0","endTime":"0","summary":"证券之星7月10日盘中消息,14点9分益诺思(688710)触及涨停板。其所属行业医疗服务目前上涨。领涨股为益诺思。该股为CAR-T疗法,干细胞,AI医疗概念热股,当日CAR-T疗法概念上涨3.88%,干细胞概念上涨3.81%,AI医疗概念上涨3.66%。7月9日的资金流向数据方面,主力资金净流入294.55万元,占总成交额2.05%,游资资金净流出72.94万元,占总成交额0.51%,散户资金净流出221.61万元,占总成交额1.54%。近5日资金流向一览见下表:益诺思主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000020839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649053694","title":"每周股票复盘:益诺思(688710)增补两名非独立董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2649053694","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649053694?lang=zh_cn&edition=full","pubTime":"2026-07-05 03:06","pubTimestamp":1783191974,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘,益诺思报收于62.67元,较上周的64.69元下跌3.12%。本周,益诺思7月2日盘中最高价报71.0元。本周关注点公司公告汇总:增补高莉、翁少羽为非独立董事。上海益诺思生物技术股份有限公司于2026年6月29日召开2026年第一次临时股东会,审议通过《董事、高级管理人员薪酬管理制度》议案,并增补高莉女士、翁少羽女士为非独立董事。所有议案均获通过,无反对或弃权情况。中小投资者对董事增补议案进行了单独计票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500000960.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647522534","title":"益诺思(688710)披露2026年第一次临时股东会决议公告,6月30日股价下跌1.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647522534","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647522534?lang=zh_cn&edition=full","pubTime":"2026-06-30 17:50","pubTimestamp":1782813055,"startTime":"0","endTime":"0","summary":"截至2026年6月30日收盘,益诺思报收于67.2元,较前一交易日下跌1.29%,最新总市值为94.74亿元。该股当日开盘66.66元,最高69.5元,最低65.78元,成交额达2.11亿元,换手率为3.42%。公司于近日披露《2026年第一次临时股东会决议公告》。公告显示,上海益诺思生物技术股份有限公司于2026年6月29日召开2026年第一次临时股东会,审议通过《董事、高级管理人员薪酬管理制度》议案,并增补高莉女士、翁少羽女士为非独立董事。所有议案均获通过,无反对或弃权情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000033433.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647322677","title":"6月29日益诺思涨5.24%,平安医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647322677","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647322677?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:47","pubTimestamp":1782722824,"startTime":"0","endTime":"0","summary":"证券之星消息,6月29日益诺思涨5.24%,收盘报68.08元,换手率3.78%,成交量3.43万手,成交额2.29亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共32家,其中持有数量最多的公募基金为平安基金的平安医疗健康混合A。平安医疗健康混合A目前规模为17.03亿元,最新净值1.9606,较上一交易日下跌2.45%,近一年下跌20.04%。平安医疗健康混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710","159760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646315547","title":"每周股票复盘:益诺思(688710)将召开临时股东会审议董事薪酬及增补两名非独立董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2646315547","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646315547?lang=zh_cn&edition=full","pubTime":"2026-06-28 03:14","pubTimestamp":1782587654,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,益诺思报收于64.69元,较上周的57.12元上涨13.25%。本周,益诺思6月26日盘中最高价报67.47元。本周关注点公司公告汇总:益诺思将召开2026年第一次临时股东会,审议董事、高管薪酬制度,并就增补高莉、翁少羽为非独立董事进行表决。因魏树源、陆伟根到龄退休,张勇因工作调整辞去董事职务,董事会提名高莉女士、翁少羽女士为非独立董事候选人,采用累积投票制选举。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645997698","title":"益诺思(688710)披露2026年第一次临时股东会会议资料,6月24日股价上涨3.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645997698","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645997698?lang=zh_cn&edition=full","pubTime":"2026-06-24 17:47","pubTimestamp":1782294449,"startTime":"0","endTime":"0","summary":"截至2026年6月24日收盘,益诺思报收于63.61元,较前一交易日上涨3.95%,最新总市值为89.68亿元。该股当日开盘61.08元,最高65.8元,最低60.04元,成交额达2.32亿元,换手率为4.0%。近日,益诺思披露《2026年第一次临时股东会会议资料》。公告显示,公司将于2026年6月29日以现场与网络投票相结合方式召开2026年第一次临时股东会,审议《董事、高级管理人员薪酬管理制度》议案,并就增补非独立董事事项进行表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400033098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645304090","title":"益诺思涨5.22%,开源证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2645304090","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645304090?lang=zh_cn&edition=full","pubTime":"2026-06-22 16:41","pubTimestamp":1782117689,"startTime":"0","endTime":"0","summary":"今日益诺思涨5.22%,收盘报60.1元。2026年3月26日,开源证券研究员余汝意发布了对益诺思的研报《公司首次覆盖报告:国资赋能的临床前CRO领先企业》,该研报对益诺思给出“买入”评级。当前股价对应2025-2027年PE分别为-242.11/63.42/38.46倍,首次覆盖,给予“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为长江证券的万梦蝶、彭英骐。益诺思个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200023667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644303706","title":"益诺思涨6.49%,开源证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2644303706","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644303706?lang=zh_cn&edition=full","pubTime":"2026-06-18 16:37","pubTimestamp":1781771872,"startTime":"0","endTime":"0","summary":"今日益诺思涨6.49%,收盘报57.12元。2026年3月26日,开源证券研究员余汝意发布了对益诺思的研报《公司首次覆盖报告:国资赋能的临床前CRO领先企业》,该研报对益诺思给出“买入”评级。当前股价对应2025-2027年PE分别为-242.11/63.42/38.46倍,首次覆盖,给予“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为长江证券的万梦蝶、彭英骐。益诺思个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800028780.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","688710"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1785148633399,"stockEarnings":[{"period":"1week","weight":0.1758},{"period":"1month","weight":0.2089},{"period":"3month","weight":0.1372},{"period":"6month","weight":0.1581},{"period":"1year","weight":0.8353},{"period":"ytd","weight":0.7418}],"compareEarnings":[{"period":"1week","weight":0.0133},{"period":"1month","weight":-0.0722},{"period":"3month","weight":-0.0651},{"period":"6month","weight":-0.0778},{"period":"1year","weight":0.0578},{"period":"ytd","weight":-0.039}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海益诺思生物技术股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"4079人(较上一季度减少12.56%)","perCapita":"22234股","listingDate":"2024-09-03","address":"上海市浦东新区中国(上海)自由贸易试验区郭守敬路199号106室","registeredCapital":"14097万元","survey":" 上海益诺思生物技术股份有限公司的主营业务是提供生物医药非临床研究服务为主的综合研发服务(CRO)。公司的主要产品是非临床CRO、临床CRO。公司荣膺医药魔方“中国创新药十年荣耀榜·行业引领CRO公司”、药融圈“中国新药临床前CRO排名TOP20”、每日经济新闻“2025上市公司最具社会责任奖”、《证券市场周刊》“金曙光新质生产力奖”等系列荣誉,并凭借在体内CAR-T领域的突出贡献,成为同写意“体内CAR-T新基建联盟成员机构”;同时获评石药集团“2025最佳合作单位”。","listedPrice":19.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"益诺思(688710)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供益诺思(688710)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"益诺思,688710,益诺思股票,益诺思股票老虎,益诺思股票老虎国际,益诺思行情,益诺思股票行情,益诺思股价,益诺思股市,益诺思股票价格,益诺思股票交易,益诺思股票购买,益诺思股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"益诺思(688710)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供益诺思(688710)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}